gilteritinib and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

gilteritinib has been researched along with Leukemia--Myelogenous--Chronic--BCR-ABL-Positive* in 1 studies

Other Studies

1 other study(ies) available for gilteritinib and Leukemia--Myelogenous--Chronic--BCR-ABL-Positive

ArticleYear
Emergence of
    Annals of laboratory medicine, 2023, 07-01, Volume: 43, Issue:4

    Topics: Aniline Compounds; Fusion Proteins, bcr-abl; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Pyrazines

2023